Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1911 1
1912 2
1916 5
1917 1
1919 5
1920 1
1921 2
1922 1
1924 3
1925 2
1926 1
1927 1
1928 3
1929 1
1931 1
1932 4
1933 1
1934 2
1936 1
1937 2
1938 15
1939 12
1940 21
1941 24
1942 14
1943 13
1944 12
1945 197
1946 723
1947 792
1948 926
1949 676
1950 1092
1951 1582
1952 1642
1953 1812
1954 1783
1955 1690
1956 1517
1957 1655
1958 1486
1959 1548
1960 1527
1961 1823
1962 1919
1963 2793
1964 9383
1965 12871
1966 13023
1967 16120
1968 18785
1969 20361
1970 21151
1971 22876
1972 23607
1973 25015
1974 25464
1975 23372
1976 22559
1977 23197
1978 23890
1979 25769
1980 25493
1981 26127
1982 28976
1983 30339
1984 32637
1985 34396
1986 35800
1987 36470
1988 38747
1989 42573
1990 45888
1991 45658
1992 46404
1993 47691
1994 48586
1995 50531
1996 52528
1997 54485
1998 58288
1999 60930
2000 65319
2001 68559
2002 74836
2003 82407
2004 86229
2005 93715
2006 100410
2007 105460
2008 111531
2009 116356
2010 126200
2011 135198
2012 142793
2013 148594
2014 154591
2015 158670
2016 158273
2017 160045
2018 162489
2019 168083
2020 189693
2021 193057
2022 166644
2023 15814
Text availability
Article attribute
Article type
Publication date

Search Results

3,851,652 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?
Jung SM, Jeon BJ, Woo J, Ryu JM, Lee SK, Chae BJ, Yu J, Kim SW, Nam SJ, Pyon JK, Mun GH, Bang SI, Lee JE. Jung SM, et al. BMC Cancer. 2021 Jan 22;21(1):88. doi: 10.1186/s12885-020-07729-w. BMC Cancer. 2021. PMID: 33482758 Free PMC article.
BACKGROUND: Immediate breast reconstruction with tissue expander in breast cancer patients who were expected to receive adjuvant therapy, such as chemotherapy or radiotherapy, has been a topic of debate. …
BACKGROUND: Immediate breast reconstruction with tissue expander in breast cancer patien
Enteral tube administration of oral chemotherapy drugs.
Spencer SH, Menard SM, Labedz MZ, Krueger CD, Sarna KV. Spencer SH, et al. J Oncol Pharm Pract. 2020 Apr;26(3):703-717. doi: 10.1177/1078155219893449. Epub 2020 Jan 19. J Oncol Pharm Pract. 2020. PMID: 31955701 Review.
OBJECTIVE: Patients receiving oral chemotherapies face treatment interruptions if they require placement of an enteral tube for nutrition, potentially leading to adverse outcomes in cancer treatment. ...The purpose of this review is to compile available data …
OBJECTIVE: Patients receiving oral chemotherapies face treatment interruptions if they require placement of an enteral tube fo …
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
Lyman GH, Abella E, Pettengell R. Lyman GH, et al. Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12. Crit Rev Oncol Hematol. 2014. PMID: 24434034 Review.
Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of myelosuppressive chemotherapy that usually results in hospitalization and the need for intravenous antibiotics. FN may result in dose reductions, delays, or even discontinuation of chemotherap
Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of myelosuppressive chemotherapy that usually results in h …
Understanding and overcoming resistance to PARP inhibitors in cancer therapy.
Dias MP, Moser SC, Ganesan S, Jonkers J. Dias MP, et al. Nat Rev Clin Oncol. 2021 Dec;18(12):773-791. doi: 10.1038/s41571-021-00532-x. Epub 2021 Jul 20. Nat Rev Clin Oncol. 2021. PMID: 34285417 Review.
The use of poly(ADP-ribose) polymerase (PARP) inhibitors in patients with homologous recombination-deficient tumours provides one of the best examples of a targeted therapy that has been successfully translated into the clinic. ...Clinical trials have demonstrated p …
The use of poly(ADP-ribose) polymerase (PARP) inhibitors in patients with homologous recombination-deficient tumours provides one of …
[Chemotherapy].
Fujita S, Kotake K. Fujita S, et al. Nihon Rinsho. 2014 Jan;72(1):102-7. Nihon Rinsho. 2014. PMID: 24597356 Review. Japanese.
Chemotherapy for colorectal cancer has improved greatly and survival rate is improving. ...Conversion rate is about 10%. Adjuvant chemotherapy is indicated for stage III patients. 5FU+LV, UFT+LV, capecitabine, FOLFOX, CapeOX and S-1 are availabl
Chemotherapy for colorectal cancer has improved greatly and survival rate is improving. ...Conversion rate is about 10%. Adjuv
[Management of chemotherapy side effects and their long-term sequelae].
Zraik IM, Heß-Busch Y. Zraik IM, et al. Urologe A. 2021 Jul;60(7):862-871. doi: 10.1007/s00120-021-01569-7. Epub 2021 Jun 29. Urologe A. 2021. PMID: 34185118 Review. German.
Various chemotherapies are used to treat testicular cancer. The most common therapy regimens are BEP (cisplatin, etoposide, bleomycin), carboplatin mono (AUC 7), PEI (cisplatin, etoposide, ifosfamide), TIP (cisplatin, ifosfamide, paclitaxel) and GOP (gemcitab …
Various chemotherapies are used to treat testicular cancer. The most common therapy regimens are BEP (cisplatin, etopos …
Alteration of DNA Methylation in Gastric Cancer with Chemotherapy.
Choi SJ, Jung SW, Huh S, Chung YS, Cho H, Kang H. Choi SJ, et al. J Microbiol Biotechnol. 2017 Aug 28;27(8):1367-1378. doi: 10.4014/jmb.1704.04035. J Microbiol Biotechnol. 2017. PMID: 28621113 Free article. Review.
These changes in DNA methylation status could be used as biomarkers for the diagnosis and prognosis of cancer patients undergoing chemotherapies or other clinical therapies. Herein, we describe genes for which methylation is dependent upon anticancer drug
These changes in DNA methylation status could be used as biomarkers for the diagnosis and prognosis of cancer patients undergo …
Artemisinin-type drugs for the treatment of hematological malignancies.
Mancuso RI, Foglio MA, Olalla Saad ST. Mancuso RI, et al. Cancer Chemother Pharmacol. 2021 Jan;87(1):1-22. doi: 10.1007/s00280-020-04170-5. Epub 2020 Nov 3. Cancer Chemother Pharmacol. 2021. PMID: 33141328 Review.
Qinghaosu, known as artemisinin (ARS), has been for over two millennia, one of the most common herbs prescribed in traditional Chinese medicine (TCM). ARS was developed as an antimalarial drug and currently belongs to the established standard treatments of malaria as a com …
Qinghaosu, known as artemisinin (ARS), has been for over two millennia, one of the most common herbs prescribed in traditional Chinese medic …
Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring.
Knezevic CE, Clarke W. Knezevic CE, et al. Ther Drug Monit. 2020 Feb;42(1):6-19. doi: 10.1097/FTD.0000000000000701. Ther Drug Monit. 2020. PMID: 31568180 Review.
The selection of an appropriate therapy and dosing regimen is a significant challenge in the treatment of cancer. ...This review discusses the challenges of dosing cytotoxic chemotherapies, dose determination strategies for cytotoxic, targeted, and antibody-b …
The selection of an appropriate therapy and dosing regimen is a significant challenge in the treatment of cancer. ...This revi …
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
Okusaka T, Furuse J. Okusaka T, et al. J Gastroenterol. 2020 Apr;55(4):369-382. doi: 10.1007/s00535-020-01666-y. Epub 2020 Jan 29. J Gastroenterol. 2020. PMID: 31997007 Free PMC article. Review.
Recent advances in treatment have been characterized by the use of novel combinations of conventional cytotoxic chemotherapies. Especially in Japan, S-1 has become one of the most widely used cytotoxic agents for the treatment of pancreatic cancer, after clin …
Recent advances in treatment have been characterized by the use of novel combinations of conventional cytotoxic chemotherapies. Espec …
3,851,652 results
You have reached the last available page of results. Please see the User Guide for more information.